88 related articles for article (PubMed ID: 22864058)
1. Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer.
Verma R; Bowen RL; Slater SE; Mihaimeed F; Jones JL
Br Med Bull; 2012 Sep; 103(1):129-45. PubMed ID: 22864058
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and outcome characteristics of inflammatory breast cancers in Brazzaville].
N'koua-M'bon JB; Bambara AT; Moukassa D; Gombé-Mbalawa C
Bull Cancer; 2013 Feb; 100(2):147-53. PubMed ID: 23392567
[TBL] [Abstract][Full Text] [Related]
3. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
4. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer.
Uematsu T
Breast Cancer; 2012 Oct; 19(4):289-94. PubMed ID: 22351245
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of inflammatory breast cancer.
Levine PH; Veneroso C
Semin Oncol; 2008 Feb; 35(1):11-6. PubMed ID: 18308141
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic disparities and breast cancer hormone receptor status.
Andaya AA; Enewold L; Horner MJ; Jatoi I; Shriver CD; Zhu K
Cancer Causes Control; 2012 Jun; 23(6):951-8. PubMed ID: 22527173
[TBL] [Abstract][Full Text] [Related]
8. Case report of bilateral inflammatory breast cancer.
Masannat YA; Peter M; Turton P; Shaaban AM
Eur J Cancer Care (Engl); 2010 Jul; 19(4):558-60. PubMed ID: 19708943
[TBL] [Abstract][Full Text] [Related]
9. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.
Van Laere S; Beissbarth T; Van der Auwera I; Van den Eynden G; Trinh XB; Elst H; Van Hummelen P; van Dam P; Van Marck E; Vermeulen P; Dirix L
Clin Cancer Res; 2008 Nov; 14(22):7452-60. PubMed ID: 19010862
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cristofanilli M; Valero V; Buzdar AU; Kau SW; Broglio KR; Gonzalez-Angulo AM; Sneige N; Islam R; Ueno NT; Buchholz TA; Singletary SE; Hortobagyi GN
Cancer; 2007 Oct; 110(7):1436-44. PubMed ID: 17694554
[TBL] [Abstract][Full Text] [Related]
11. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of different subtypes of breast cancer].
Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
[TBL] [Abstract][Full Text] [Related]
13. Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?
Lê MG; Arriagada R; Bahi J; Pfeiffer F; Cammoun M; Tabbane F; Rubino C
Breast; 2006 Jun; 15(3):355-62. PubMed ID: 16198566
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer.
Zaha DC; Lazăr E; Lăzureanu C
Rom J Morphol Embryol; 2010; 51(1):85-9. PubMed ID: 20191125
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer: a socioeconomic and racial comparison in northwest Louisiana.
Li A; Burton G; Glass J
J La State Med Soc; 2001 Aug; 153(8):420-5. PubMed ID: 11565639
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
17. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.
Menta A; Fouad TM; Lucci A; Le-Petross H; Stauder MC; Woodward WA; Ueno NT; Lim B
Surg Clin North Am; 2018 Aug; 98(4):787-800. PubMed ID: 30005774
[TBL] [Abstract][Full Text] [Related]
19. Contralateral breast cancer: factors associated with stage and size at presentation.
Mertens WC; Hilbert V; Makari-Judson G
Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
